Edward R. Conner
CIK 1691265 · View on SEC EDGAR ↗
First SEC filing: Oct. 17, 2025 · Latest: Oct. 17, 2025
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 2, 2022 | ELVN | A | 8,500 | — | — | 8,500 Direct | — | Acquired | (price as of 2026-08-20) |
| June 29, 2021 | ELVN | A | 7,728 | — | — | 7,728 Direct | — | Acquired | (price as of 2026-08-20) |
| April 22, 2020 | ELVN | A | 15,457 | — | — | 15,457 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 2, 2022 | ELVN | Stock Options (Right to Buy) | Common Stock (8,500) | $1.07 | June 1, 2032 | 8,500 | Acquired |
| June 29, 2021 | ELVN | Stock Options (Right to Buy) | Common Stock (7,728) | $8.12 | June 28, 2031 | 7,728 | Acquired |
| April 22, 2020 | ELVN | Stock Option (right to buy) | Common Stock (15,457) | $16.00 | April 21, 2030 | 15,457 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ARDX
M.D.(6)Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $213,019 | — | $1,574,775 | $1,836,116 | — | — | — | $3,623,910 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.